AKT1 and neoplasm: Akt activation promotes glycolytic metabolism by increasing glucose transporter expression and hexokinase phosphorylation, inhibits apoptosis via phosphorylation of pro-apoptotic proteins (e.g., BAD, FOXO), and enhances mTORC1-driven protein synthesis—all of which support tumor progression (Figure 4) [110,111,112].